Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Inflammation clues after heart attack could predict future risks

NCT ID NCT06065514

Knowledge-focused Sponsor: Nicosia General Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 100 people who had a heart attack to see if certain inflammation markers in the blood could predict who might die or develop heart failure within 6 months. Researchers measured these markers at several time points after the attack. The goal was to better understand how inflammation affects heart healing, not to test a new treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

100 people

The number who actually took part.

Started

Aug 2023

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients with acute coronary syndromes (ST-ACS, NSTE-ACS, UA), who underwent coronary angiography.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. ACS (ST-ACS, NSTE-ACS, UA) referred for coronary angiography 2. Above 18 years old 3. Consent form obtained Exclusion Criteria: 1. Chronic Renal Failure (CRF) stage IV (e GFR \< 29 ml/min or creatinine \> 2 mg/dl) 2. Chronic Liver Disease (CLD) (ALT \> 2 times upper normal limit) 3. Chronic Inflammation and/or autoimmune diseases 4. Active Ca 5. Recent CVA (less than 1 month) 6. Recent (within 2 weeks) use of glucocorticoid drugs or immunosuppressive agents 7. Acute or chronic infection, major surgery, or trauma in the last month 8. Previous heart transplantation 9. Poor life expectancy 10. Cardiogenic shock 11. Cardiac arrest

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute myocardial infarction are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

acute myocardial infarction Inflammation intermediate coronary syndrome myocardial infarction Non-ST Elevated Myocardial Infarction ST-elevation myocardial infarction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Myocardial infarction

Contacts and locations

Locations

  • 1st University Department of Cardiology - AHEPA University Hospital

    Thessaloniki, Greece, Greece

  • 2nd University Department of Cardiology

    Thessaloniki, Greece, Greece

  • 3rd University Department of Cardiology

    Thessaloniki, Greece, Greece

  • Nicosia General Hospital

    Nicosia, Nicosia, 2029, Cyprus

More trials for these conditions

Other studies related to the condition(s) this trial covers.